EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer

Published:2004-02-01 Issue:3 Volume:64 Page:781-788
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Mao Weiguang,Luis Elizabeth,Ross Sarajane,Silva Johnny,Tan Christine,Crowley Craig,Chui Clarissa,Franz Gretchen,Senter Peter,Koeppen Hartmut,Polakis Paul

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced EphB2-Specific Peptide Inhibitors through Stabilization of Polyproline II Helical Structure;ACS Chemical Biology;2024-05-13

2. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets;Frontiers in Oncology;2024-04-02

3. The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies;International Journal of Molecular Sciences;2024-03-29

4. The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling;Cell Death & Disease;2023-11-18

5. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP